Ozurdex and Uveitis - a phase IV clinical study of FDA data

Summary:

Uveitis is reported as a side effect among people who take Ozurdex (dexamethasone), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Humira, and have Macular oedema.

The phase IV clinical study analyzes which people have Uveitis when taking Ozurdex. It is created by eHealthMe based on reports of 2,488 people who have side effects when taking Ozurdex from the FDA, and is updated regularly.

What is Ozurdex?

Ozurdex has active ingredients of dexamethasone. eHealthMe is studying from 2,497 Ozurdex users. Check the latest studies of Ozurdex.

What is Uveitis?

Uveitis (inflammation of the uvea) is found to be associated with 831 drugs and 1,528 conditions by eHealthMe. Check the latest studies of Uveitis.

On Jul, 11, 2026

2,488 people reported to have side effects when taking Ozurdex.
Among them, 76 people (3.05%) have Uveitis.

Among these 76 people:

How long have people been on Ozurdex when they have Uveitis? *

What is the gender of people who have Uveitis when taking Ozurdex? *

female: 50.7 %
male: 49.3 %

What is the age of people who have Uveitis when taking Ozurdex? *

What are other drugs people take besides Ozurdex? *

Humira: 13 people, 17.11%
Maxidex: 7 people, 9.21%
Cyclosporine: 7 people, 9.21%
Prednisone: 6 people, 7.89%
Dexamethasone: 6 people, 7.89%
Combigan: 5 people, 6.58%
Ciprofloxacin: 5 people, 6.58%
Dexamethasone Sodium Phosphate: 5 people, 6.58%
Tobramycin: 4 people, 5.26%
Triamcinolone Acetonide: 4 people, 5.26%

What are other side effects people have besides Uveitis? *

Drug Ineffective: 21 people, 27.63%
Visual Acuity Reduced (reduced clearness of vision): 19 people, 25.00%
Endophthalmitis (inflammation of the internal coats of the eye): 16 people, 21.05%
Eye Pain: 16 people, 21.05%
Intraocular Pressure Increased: 16 people, 21.05%
Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 15 people, 19.74%
Visual Impairment: 11 people, 14.47%
Vitreous Floaters (spots before the eyes): 6 people, 7.89%
Iridocyclitis (inflammation of the iris and ciliary body of the eye): 6 people, 7.89%
Chondritis (inflammation of cartilage): 6 people, 7.89%

What are the existing conditions these people have? *

Macular Oedema (fluid and protein deposits collect on or under the macula of the eye (a yellow central area of the retina) and causes it to thicken): 25 people, 32.89%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 11 people, 14.47%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 11 people, 14.47%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 9 people, 11.84%
Iridocyclitis (inflammation of the iris and ciliary body of the eye): 9 people, 11.84%
Endophthalmitis (inflammation of the internal coats of the eye): 9 people, 11.84%
Sympathetic Ophthalmia (inflammatory condition affecting both eyes that occurs after a penetrating injury): 7 people, 9.21%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 7.89%
Adverse Event: 4 people, 5.26%
Intraocular Pressure Increased: 4 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ozurdex and have Uveitis?

- Check whether Uveitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ozurdex:

Ozurdex (2,497 reports)

Uveitis treatments and more:

Uveitis (29,545 reports)

Browse all side effects of Ozurdex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Uveitis:

Uveitis (831 drugs)

Browse all the conditions that are associated with Uveitis:

Uveitis (1,528 conditions)

Related publications that referenced our studies

Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .
Bartlett R, Hartle AJ, "Routine use of dexamethasone for postoperative nausea and vomiting: the case against", Anaesthesia, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on dexamethasone (the active ingredients of Ozurdex) and Ozurdex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.